Clinical trial · Observational
Prevalence of HbA1C in Women With PCOS
Prevalence of HbA1C in Different Categories of Obesity in Women With PCOS'A Propective Randomized Control Study
NCT01838122CI-TRIAL-00010116WHIunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Women with PCOS have been observed to be potential diabetics.Recently,American Diabetes Association has suggested screening of women with PCOS for HbA1C.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Insulin Resistance | — | UNRESOLVED | — |
| Non-insulin Dependent Diabetes Mellitus | — | UNRESOLVED | — |
| Pelvic Endometriosis | — | UNRESOLVED | — |
| Polycystic Ovarian Syndrome | — | UNRESOLVED | — |
| Tubal Obstruction | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Study Arm
- description
- This group/cohort will have subjects having infertility due to PCOS (as per Rotterdam criteria)
- label
- Control arm
- description
- This group/cohort will have subjects without PCOS but with any other diagnosis of infertility or any other complain.
Primary outcomes (1)
- measure
- Prevalence of HbA1C in both arms of the cohort of subjects
- timeFrame
- September 2013
- description
- HbA1C has been suggested as a potential marker for NIDDM in subjects with PCOS
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 15 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: 1. BMI of 25-35 Kg/Mt2 2. Atleast three of the Rotterdam criteria for diagnosis of PCOS. 3. Subjects with well stabilized Thyroid,if they had documented evidence of previousthyroid disorder. Exclusion Criteria: 1. Subjects with documented diagnosis of Metabolic Syndrome. 2. Subjects with laparocopic and histopathologic diagnosis of Endometriosis. 3Subjects with Primary hyperprolectineamia. 4.Subjects with basal FSH \>/=15mIU/ml. 5.Subjects with continuously elevated 17-0h-p.
References
Publications (1)
- RESULTJin JU Kim,Young Min Choi et al.Human Reproduction 27(5),1439-1444,2013.